Rihanna Spotted Heading to César Restaurant in Paris After Céline Dion Concert
By Rodrigo Santos Andrade
J&J’s $1.7 Billion Drug Ushers in Age of Psychedelic Medicine
visibility comment0 event May 2, 2026 timer 05:00
Spravato, the ketamine-derived nasal spray from Johnson & Johnson, was once seen as a long shot. It was difficult to deliver, heavily regulated and slow to catch on. Find out how it became a billion-dollar drug and part of a new model for treating depression.
Watch more mini documentaries from Bloomberg: https://www.youtube.com/playlist?list=PLGaYlBJIOoa_EzzMpticURNR29AiQi10v
The $1.7 Billion Trip: https://www.bloomberg.com/features/2026-jjs-spravato-psychedelic-blockbuster-drug/
How J&J leveraged insurance to turn Spravato into a blockbuster depression drug.
Like this video? Subscribe and turn on notifications so you don’t miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9
Visit http://www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more.
#Ketamine #Science #Business
Tags: Bloomberg, Bloomberg Finance, Bloomberg Makets, Bloomberg Media, Bloomberg Stocks Markets, Bloomberg Television, Bloomberg Television News Videos, Bloomberg TV, Bloomberg Videos, Breaking News, Breaking World News, Business News, International News, Latest National News, Latest News and Videos, Latest World News, World News
No Comments
